Sickle Cell Anemia Therapeutics Market Revenue 2024 to 2034
Sickle Cell Anemia Therapeutics Market Revenue 2024 to 2034
The Sickle Cell Anemia Therapeutics Market is expected to expand from USD 17.63 Bn in 2024 to USD 71.67 Bn by 2034, at a CAGR of 15.0%. Growth is fueled by rising prevalence of sickle cell disease, increasing adoption of gene therapies, and advancements in targeted treatment options worldwide.
Report ID: 10335
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 29.62 Bn
Forecast Year,
USD 48.94 Bn
CAGR, 2025 -
5.15%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Sickle Cell Anemia Therapeutics Market Size Analysis
Sickle Cell Anemia Therapeutics Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 9.48 | 10.05 | 10.54 | 11.12 | 11.61 | 12.15 | 12.71 | 13.32 | 14.02 | 14.74 | 15.54 |
| Biologics | 10.07 | 10.60 | 11.21 | 11.72 | 12.39 | 13.10 | 13.82 | 14.57 | 15.34 | 16.09 | 16.85 |
| Advanced Therapies | 5.33 | 5.56 | 5.85 | 6.14 | 6.47 | 6.83 | 7.17 | 7.60 | 7.97 | 8.43 | 8.88 |
| Others | 4.74 | 4.93 | 5.15 | 5.45 | 5.74 | 5.99 | 6.32 | 6.60 | 6.94 | 7.29 | 7.67 |
Sickle Cell Anemia Therapeutics Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 10.66 | 11.17 | 11.72 | 12.31 | 13.01 | 13.66 | 14.37 | 15.14 | 15.91 | 16.72 | 17.60 |
| Cardio-Metabolic | 5.33 | 5.57 | 5.85 | 6.17 | 6.46 | 6.82 | 7.11 | 7.43 | 7.76 | 8.15 | 8.54 |
| Infectious | 4.74 | 5.00 | 5.28 | 5.54 | 5.85 | 6.15 | 6.52 | 6.89 | 7.30 | 7.62 | 8.00 |
| CNS | 4.15 | 4.36 | 4.60 | 4.82 | 5.04 | 5.32 | 5.59 | 5.89 | 6.20 | 6.55 | 6.92 |
| Others | 4.74 | 5.03 | 5.29 | 5.59 | 5.84 | 6.12 | 6.44 | 6.74 | 7.09 | 7.50 | 7.88 |
Sickle Cell Anemia Therapeutics Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 13.03 | 13.68 | 14.43 | 15.14 | 16.02 | 16.81 | 17.68 | 18.63 | 19.80 | 20.89 | 22.00 |
| Retail Pharmacy | 10.66 | 11.23 | 11.75 | 12.41 | 12.97 | 13.70 | 14.38 | 15.13 | 15.71 | 16.50 | 17.35 |
| Online/Other | 5.92 | 6.24 | 6.57 | 6.89 | 7.21 | 7.56 | 7.97 | 8.34 | 8.75 | 9.15 | 9.59 |
Sickle Cell Anemia Therapeutics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 11.85 | 12.54 | 13.13 | 13.83 | 14.59 | 15.34 | 16.12 | 16.87 | 17.68 | 18.55 | 19.61 |
| Europe | 8.29 | 8.65 | 9.18 | 9.63 | 10.10 | 10.66 | 11.20 | 11.84 | 12.50 | 13.19 | 13.80 |
| Asia Pacific | 7.11 | 7.47 | 7.82 | 8.22 | 8.61 | 9.02 | 9.53 | 10.04 | 10.56 | 11.12 | 11.65 |
| Latin America | 1.18 | 1.24 | 1.30 | 1.38 | 1.46 | 1.53 | 1.60 | 1.69 | 1.78 | 1.86 | 1.94 |
| Middle East & Africa | 1.18 | 1.24 | 1.31 | 1.38 | 1.45 | 1.51 | 1.58 | 1.66 | 1.74 | 1.83 | 1.93 |
Sickle Cell Anemia Therapeutics Market
Sickle Cell Anemia Therapeutics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
